Page 79 - GHES-3-3

Global Health Economics and
Sustainability
Pharmaceutical system in Iraq

pharmaceutical market post-2003. Pharmaceutical Drug survey. BMC International Health and Human Rights, 11:15.
Regulatory Affairs Journal, 2(2):000116.
https://doi.org/10.1186/1472-698x-11-15
https://doi.org/10.23880/pdraj-16000116
Cetorelli, V., & Shabila, N.P. (2014). Expansion of health facilities
Al-Jumaili, A.A., Hussain, S.A., & Sorofman, B. (2013). in Iraq a decade after the US-led invasion, 2003-2012.
Pharmacy in Iraq: History, current status, and future Conflict and Health, 8:16.
directions. American Journal of Health-System Pharmacy, https://doi.org/10.1186/1752-1505-8-16
70(4):368-372.
Chaudhry, B., Wang, J., Wu, S., Maglione, M., Mojica, W.,
https://doi.org/10.2146/ajhp120415
Roth, E., et al. (2006). Systematic review: Impact of health
Al-Jumaili, A.A., Sami, S.G., & Al-Rekabi, M.D. (2021). The information technology on quality, efficiency, and costs of
preparedness of public healthcare settings and providers to medical care. Annals of Internal Medicine, 144(10):742-752.
face the COVID-19 pandemic. Latin American Journal of https://doi.org/10.7326/0003-4819-144-10-200605160-
Pharmacy, 40:15-22.
00125
Al-Jumaili, A.A., Younus, M.M., Kannan, Y.J.A., Nooruldeen, Z.E., Frost and Sullivan. (2018). Assessment of Opportunities in Iraq,
& Al-Nuseirat, A. (2021). Pharmaceutical regulations in an Untapped Market. Frost and Sullivan. Available from:
Iraq: From medicine approval to postmarketing. Eastern https://store.frost.com/assessment-of-opportunities-in-
Mediterranean Health Journal, 27(10):1007-1015.
iraq-an-untapped -market-2018.html [Last accessed on
https://doi.org/10.26719/emhj.21.025 2024 Sep 01].
Al-Jumaili, A.A.A., Jabri, A.M., Al-Rekabi, M.D., Abbood, S.K., Hadzović, S. (1997). Pharmacy and the great contribution of
& Hussein, A.H. (2016). Physician acceptance of pharmacist Arab-Islamic science to its development. Medical Archives,
recommendations about medication prescribing errors in 51(1-2):47-50.
Iraqi hospitals. Innovations in Pharmacy, 7(3):9.
Hussain, A., & Lafta, R. (2019). Burden of non-communicable
https://doi.org/10.24926/iip.v7i3.443. diseases in Iraq after the 2003 war. Saudi Medical Journal,
40(1):72-78.
Al-Kinani, K.K., Ibrahim, M.J., Al-Zubaidi, R.F., Younus, M.M.,
Ramadhan, S.H., Kadhim, H.J., et al. (2020). Iraqi regulatory https://doi.org/10.15537/smj.2019.1.23463
authority current system and experience with biosimilars. Ibrahim, S., Al-Dahir, S., Al Mulla, T., Lami, F., Hossain, S.M.M.,
Regulatory Toxicology and Pharmacology, 117:104768.
Baqui, A., et al. (2021). Resilience of health systems in
https://doi.org/10.1016/j.yrtph.2020.104768 conflict affected governorates of Iraq, 2014-2018. Conflict
and Health, 15(1):76.
Al-Lela, O.Q.B., BaderAldeen, S.K., Elkalmi, R.M., & Jawad
Awadh, A.I. (2012). Pharmacy Education in Iraq. American https://doi.org/10.1186/s13031-021-00412-2
Journal of Pharmaceutical Education, 76(9):183.
Institute of Medicine. (2000). To Err s Human: Building a Safer
https://doi.org/10.5688/ajpe769183 Health System. Washington, DC: National Academies Press.
Al-Mosawi, A. (2020). Iraq healthcare system: An update. Lupine https://doi.org/10.17226/9728
Online Journal of Medical Sciences, 4(2):404-411.
Institute of Medicine. (2001). Crossing the Quality Chasm:
https://doi.org/10.32474/LOJMS.2020.04.000190 A New Health System for the 21 Century. Washington, DC:
st
National Academies Press.
Al-Taie, A. (2020). Insights into clinical pharmacy program in
Iraq: Current trends and upgrading plans. Jordan Journal of https://doi.org/10.17226/10027
Pharmaceutical Sciences, 13(3):265-271.
International Monetary Fund. (2023). World Economic Outlook:
Boehme, A.K., Esenwa, C., & Elkind, M.S.V. (2017). Stroke Risk Navigating Global Divergences. Washington, DC, USA:
Factors, Genetics, and Prevention. Circulation Research, International Monetary Fund.
120(3):472-495.
Lane, R., & Al Hilfi T., K. (2013). Looking ahead to a healthier
https://doi.org/10.1161/CIRCRESAHA.116.308398 Iraq. The Lancet, 381(9870), 897.
Borchardt, J.K. (2002). The beginnings of drug therapy: Ancient https://doi.org/10.1016/s0140-6736(13)60661-3
mesopotamian medicine. Drug News and Perspectives, Management Partners. (2013). Iraq Pharmaceuticals Market
15(3):187.
Opportunities. Management Partners. Available from:
https://doi.org/10.1358/dnp.2002.15.3.840015 https://www.m-partners. biz/files/6414/2062/5670/iraq_
pharmaceuticals_market_opportunities.pdf [Last accessed
Burnham, G., Hoe, C., Hung, Y.W., Ferati, A., Dyer, A., Hifi, T.A.,
et al. (2011). Perceptions and utilization of primary health on 2024 Sep 01].
care services in Iraq: Findings from a national household Matsunaga, H. (2019). The Reconstruction of Iraq after

Volume 3 Issue 3 (2025) 71 https://doi.org/10.36922/GHES025110025